{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T08:23:07Z","timestamp":1763194987846,"version":"3.45.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170150"],"award-info":[{"award-number":["82170150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7192066"],"award-info":[{"award-number":["7192066"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06582-w","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T07:23:39Z","timestamp":1758525819000},"page":"5273-5282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["USP7 mutations are associated with adverse outcomes in pediatric T cell acute lymphoblastic leukemia and lymphoma"],"prefix":"10.1007","volume":"104","author":[{"given":"Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Feng","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Long","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"issue":"14","key":"6582_CR1","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1182\/bloodadvances.2020001822","volume":"4","author":"E Kroeze","year":"2020","unstructured":"Kroeze E, Loeffen JLC, Poort VM et al (2020) T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor? Blood Adv 4(14):3466\u20133473","journal-title":"Blood Adv"},{"key":"6582_CR2","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36(7):1720\u20131748","DOI":"10.1038\/s41375-022-01620-2"},{"key":"6582_CR3","doi-asserted-by":"crossref","unstructured":"Morita-Fujita M, Arai Y, Yoshioka S et al (2020) Kyoto Stem Cell Transplantation group (KSCTG). Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies. Sci Rep 10(1):21418","DOI":"10.1038\/s41598-020-78334-x"},{"issue":"28","key":"6582_CR4","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1200\/JCO.20.00256","volume":"38","author":"KP Dunsmore","year":"2020","unstructured":"Dunsmore KP, Winter SS, Devidas M et al (2020) Children\u2019s oncology group AALL0434: a phase III randomized clinical trial testing nelarabine in newly diagnosed T-cell acute lymphoblastic leukemia. J Clin Oncol 38(28):3282\u20133293","journal-title":"J Clin Oncol"},{"issue":"25","key":"6582_CR5","first-page":"3019","volume":"141","author":"SJ Si Lim","year":"2023","unstructured":"Si Lim SJ, Ford JB, Hermiston ML et al (2023) How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults. Blood 141(25):3019\u20133030","journal-title":"Blood"},{"key":"6582_CR6","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1038\/ncomms4630","volume":"5","author":"R Huether","year":"2014","unstructured":"Huether R, Dong L, Chen X et al (2014) The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nat Commun 5:3630","journal-title":"Nat Commun"},{"key":"6582_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.3","author":"P Richter-Pecha\u0144ska","year":"2017","unstructured":"Richter-Pecha\u0144ska P, Kunz JB, Hof J et al (2017) Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia. Blood Cancer J. https:\/\/doi.org\/10.1038\/bcj.2017.3","journal-title":"Blood Cancer J"},{"issue":"8","key":"6582_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu Y, Easton J, Shao Y et al (2017) The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet 49(8):1211\u20131218","journal-title":"Nat Genet"},{"issue":"12","key":"6582_CR9","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/jnci\/djz043","volume":"111","author":"M Qian","year":"2019","unstructured":"Qian M, Zhao X, Devidas M et al (2019) Genome-wide association study of susceptibility loci for T-cell acute lymphoblastic leukemia in children. J Natl Cancer Inst 111(12):1350\u20131357","journal-title":"J Natl Cancer Inst"},{"key":"6582_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41392-018-0028-3","volume":"3","author":"H Shan","year":"2018","unstructured":"Shan H, Li X, Xiao X et al (2018) USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia. Signal Transduct Target Ther 3:29","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"6582_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1365-2141.2009.07607.x","volume":"145","author":"MJ Park","year":"2009","unstructured":"Park MJ, Taki T, Oda M et al (2009) FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma. Br J Haematol 145(2):198\u2013206","journal-title":"Br J Haematol"},{"key":"6582_CR12","doi-asserted-by":"crossref","unstructured":"Gao C, Zhao XX, Li WJ et al (2012) Am J Hematol 87(11):1022\u20137","DOI":"10.1002\/ajh.23307"},{"issue":"6","key":"6582_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/ejh.13948","volume":"110","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li J, Xue TL et al (2023) Clinical, biological, and outcome features of P2RY8-CRLF2 and CRLF2 over-expression in pediatric B-cell precursor acute lymphoblastic leukemia according to the CCLG-ALL 2008 and 2018 protocol. Eur J Haematol 110(6):669\u2013679","journal-title":"Eur J Haematol"},{"issue":"29","key":"6582_CR14","first-page":"2759","volume":"104","author":"L Jin","year":"2024","unstructured":"Jin L, Yang J, Duan YL et al (2024) Long-term efficacy and prognostic factors of Beijing Children\u2019s Hospital-2009-lymphoblastic lymphoma in the treatment of T-lymphoblastic lymphoma in children and adolescents. Zhonghua Yi Xue Za Zhi 104(29):2759\u20132766","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"6582_CR15","unstructured":"https:\/\/www.gov.cn\/zhengce\/zhengceku\/2019-11\/15\/5452452\/files\/9cc1df76296844308e797fc7744305fa.pdf"},{"issue":"2","key":"6582_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/bjh.12866","volume":"166","author":"C Gao","year":"2014","unstructured":"Gao C, Liu SG, Zhang RD et al (2014) NOTCH1 mutations are associated with favourable long-term prognosis in paediatric T-cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH-2003 and CCLG-2008 protocol in China. Br J Haematol 166(2):221\u20138","journal-title":"Br J Haematol"},{"issue":"7","key":"6582_CR17","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1080\/10428194.2022.2032033","volume":"63","author":"Y Yuan","year":"2022","unstructured":"Yuan Y, Li J, Xue TL et al (2022) Prognostic significance of NOTCH1\/FBXW7 mutations in pediatric T cell acute lymphoblastic leukemia: a study of minimal residual disease risk-directed CCLG-ALL 2008 treatment protocol. Leuk Lymphoma 63(7):1624\u20131633","journal-title":"Leuk Lymphoma"},{"key":"6582_CR18","doi-asserted-by":"crossref","unstructured":"Saha G, Roy S, Basu M et al (1878) (2023) USP7 - a crucial regulator of cancer hallmarks. Biochim Biophys Acta Rev Cancer\u00a01878(2):188903","DOI":"10.1016\/j.bbcan.2023.188903"},{"key":"6582_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.dnarep.2019.02.005","volume":"76","author":"A Pozhidaeva","year":"2019","unstructured":"Pozhidaeva A, Bezsonova I (2019) USP7: structure, substrate specificity, and inhibition. DNA Repair (Amst) 76:30\u201339","journal-title":"DNA Repair (Amst)"},{"key":"6582_CR20","doi-asserted-by":"crossref","unstructured":"Richter-Pecha\u0144ska P, Kunz JB, Hof J et al (2017) Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia. Blood Cancer J 7:e523","DOI":"10.1038\/bcj.2017.3"},{"key":"6582_CR21","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1038\/ncomms4630","volume":"5","author":"R Huether","year":"2014","unstructured":"Huether R, Dong L, Chen X et al (2014) The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nat Commun 5:3630","journal-title":"Nat Commun"},{"key":"6582_CR22","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu Y, Easton J, Shao Y et al (2017) The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet 49:1211\u20131218","journal-title":"Nat Genet"},{"key":"6582_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W et al (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269\u2013271","journal-title":"Science"},{"key":"6582_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/bjh.12866","volume":"166","author":"C Gao","year":"2014","unstructured":"Gao C, Liu S-G, Zhang R-D et al (2014) NOTCH1 mutations are associated with favourable long-term prognosis in paediatric T-cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH-2003 and CCLG-2008 protocol in China. Br J Haematol 166:221\u2013228","journal-title":"Br J Haematol"},{"key":"6582_CR25","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1038\/leu.2010.205","volume":"24","author":"E Clappier","year":"2010","unstructured":"Clappier E, Collette S, Grardel N et al (2010) NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia 24:2023\u20132031","journal-title":"Leukemia"},{"key":"6582_CR26","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.1158\/0008-5472.CAN-06-4381","volume":"67","author":"A Malyukova","year":"2007","unstructured":"Malyukova A, Dohda T, von der Lehr N et al (2007) The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Cancer Res 67:5611\u20135616","journal-title":"Cancer Res"},{"key":"6582_CR27","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1084\/jem.20070876","volume":"204","author":"J O\u2019Neil","year":"2007","unstructured":"O\u2019Neil J, Grim J, Strack P et al (2007) FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 204:1813\u20131824","journal-title":"J Exp Med"},{"key":"6582_CR28","doi-asserted-by":"crossref","unstructured":"Valliyammai N, Nancy NK, Sagar TG, Rajkumar T (2018) Study of NOTCH1 and FBXW7 Mutations and Its Prognostic Significance in South Indian T-Cell Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol 40:e1\u2013e8","DOI":"10.1097\/MPH.0000000000001006"},{"key":"6582_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","volume":"114","author":"A Gutierrez","year":"2009","unstructured":"Gutierrez A, Sanda T, Grebliunaite R et al (2009) High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood 114:647\u2013650","journal-title":"Blood"},{"key":"6582_CR30","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3324\/haematol.2011.059030","volume":"97","author":"L Zuurbier","year":"2012","unstructured":"Zuurbier L, Petricoin EF, Vuerhard MJ et al (2012) The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia. Haematologica 97:1405\u20131413","journal-title":"Haematologica"},{"key":"6582_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/leu.2009.209","volume":"24","author":"PY Jotta","year":"2010","unstructured":"Jotta PY, Ganazza MA, Silva A et al (2010) Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia. Leukemia 24:239\u2013242","journal-title":"Leukemia"},{"key":"6582_CR32","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1038\/leu.2017.157","volume":"31","author":"M Tesio","year":"2017","unstructured":"Tesio M, Trinquand A, Ballerini P et al (2017) Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia. Leukemia 31:2594\u20132600","journal-title":"Leukemia"},{"key":"6582_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/bjh.15449","volume":"182","author":"M Paganin","year":"2018","unstructured":"Paganin M, Grillo MF, Silvestri D et al (2018) The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols. Br J Haematol 182:705\u2013711","journal-title":"Br J Haematol"},{"key":"6582_CR34","doi-asserted-by":"crossref","unstructured":"Szarzy\u0144ska-Zawadzka B, Kunz JB, S\u0119dek \u0141 et al (2019) PTEN abnormalities predict poor outcome in children with T-cell acute lymphoblastic leukemia treated according to ALL IC-BFM protocols. Am J Hematol 94:E93\u2013E96","DOI":"10.1002\/ajh.25396"},{"key":"6582_CR35","doi-asserted-by":"crossref","unstructured":"Lejman M, W\u0142odarczyk M, Styka B et al (2020) Advantages and Limitations of SNP Array in the Molecular Characterization of Pediatric T-Cell Acute Lymphoblastic Leukemia. Front Oncol 10:1184","DOI":"10.3389\/fonc.2020.01184"},{"key":"6582_CR36","doi-asserted-by":"crossref","unstructured":"Teachey DT, Pui C-H (2019) Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia. Lancet Oncol 20:e142\u2013e154","DOI":"10.1016\/S1470-2045(19)30031-2"},{"key":"6582_CR37","doi-asserted-by":"crossref","unstructured":"Yeh T-C, Liang D-C, Liu H-C et al (2019) Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan. Pediatr Blood Cancer 66:e27496","DOI":"10.1002\/pbc.27496"},{"key":"6582_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1182\/blood-2017-04-778829","volume":"131","author":"A Petit","year":"2018","unstructured":"Petit A, Trinquand A, Chevret S et al (2018) Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia. Blood 131:289\u2013300","journal-title":"Blood"},{"key":"6582_CR39","doi-asserted-by":"publisher","first-page":"11306","DOI":"10.1073\/pnas.1608420113","volume":"113","author":"K Oshima","year":"2016","unstructured":"Oshima K, Khiabanian H, da Silva-Almeida AC et al (2016) Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 113:11306\u201311311","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6582_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2024.115619","author":"B \u00d6zay","year":"2024","unstructured":"\u00d6zay B, T\u00fckel EY, Ayna Duran G et al (2024) Identification of potential inhibitors for drug resistance in acute lymphoblastic leukemia through differentially expressed gene analysis and in silico screening. Anal Biochem. https:\/\/doi.org\/10.1016\/j.ab.2024.115619","journal-title":"Anal Biochem"},{"key":"6582_CR41","doi-asserted-by":"crossref","unstructured":"Jin Q, Gutierrez Diaz B, Pieters T et al (2022) Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia. Sci Adv 8(49):eabq8437","DOI":"10.1126\/sciadv.abq8437"},{"issue":"1","key":"6582_CR42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1158\/1078-0432.CCR-18-1740","volume":"25","author":"Q Jin","year":"2022","unstructured":"Jin Q, Martinez CA, Arcipowski KM et al (2022) USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia. Clin Cancer Res 25(1):222\u2013239","journal-title":"Clin Cancer Res"},{"issue":"9","key":"6582_CR43","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1158\/2159-8290.CD-19-1436","volume":"10","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Han C, Wang E et al (2022) Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia. Cancer Discov 10(9):1388\u20131409","journal-title":"Cancer Discov"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06582-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06582-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06582-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T08:19:07Z","timestamp":1763194747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06582-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["6582"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06582-w","relation":{},"ISSN":["1432-0584"],"issn-type":[{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. All procedures involving human participants were approved.\u00a0This study was granted an exemption from informed consent as it constitutes aretrospective anonymous study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Additional Supporting information may be found in the online version of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Supporting information"}}]}}